Luteolin blocks the ROS/PI3K/AKT pathway to inhibit mesothelial-mesenchymal transition and reduce abdominal adhesions.
Ren Y, Li G, Li E, Deng K, Lian J, Gao Q, Wang H, Wang X, Wang Z, Shen T, Jiang Z, Li X, Qiu G.
Ren Y, et al. Among authors: li e, li g, li x.
Eur J Pharmacol. 2024 Feb 5;964:176272. doi: 10.1016/j.ejphar.2023.176272. Epub 2023 Dec 16.
Eur J Pharmacol. 2024.
PMID: 38110140
Free article.